The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2008: Volume 13/ Issue 1 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 13, Issue 1, 03 January 2008
Chikungunya virus in north-eastern Italy: a consequence of seasonal synchronicity

Citation style for this article: Chikungunya virus in north-eastern Italy: a consequence of seasonal synchronicity. Euro Surveill. 2008;13(1):pii=8003. Available online:


To the Editor: In their recent article on the outbreak of chikungunya virus infection in North-eastern Italy, Angelini et al. [1] raised an important question: Why did no other outbreaks of chikungunya fever occur earlier in other regions of Italy or more widely in Europe? Why did they not occur already in 2005-2006, after the epidemic in La Reunion and other Indian Ocean islands - Comoros, Mayotte, the Seychelles, Mauritius and Madagascar, as a consequence of viraemic travellers carrying chikungunya virus when returning from the epidemic areas? Among the possible explanations, the authors listed (a) the fact that only few regions (including the affected areas) have a high concentration of competent vectors, and (b) social and behavioural factors of the returning travellers.

We would suggest to consider seasonal synchronicity as a third factor that has obviously played a decisive role in the outbreak in July to September in the surroundings of Ravenna (Emilia Romagna), Italy.
The outbreak in the Indian Ocean islands has raged for a six-month period, from January to June 2006, and had an estimated number of cases approaching one million. The epidemic in the islands then subsided rapidly due to decreased mosquito activity in the dry season in southern hemisphere. In 2007, chikungunya virus did not re-emerge in the Indian Ocean area as feared. Consequently, viraemic travellers from Europe must have been returning to their home countries at a time when the mosquitoes that serve as vectors for chikungunya virus were either not circulating or still scarce in Europe.
In contrast, first cases of chikungunya fever in India were reported in February 2006. Ultimately, this epidemic spread to many districts in India and many cases occurred in the course of the year 2006. The activity of Aedes aegypti and Ae. albopictus in India is constant throughout the year; cases have been reported continuously up to December 2007. As a consequence, travellers could have become infected with chikungunya virus in India, and returned during the viraemic period to European regions at a time when competent vectors were active there (summer). Due to the overlapping mosquito season in India and Europe, travellers returning from India can thus fuel an epidemic by infecting native mosquito populations in Europe.
Seasonal synchronicity, and related temporal overlapping of arthropod activity, is a critical factor that needs to be considered in the prediction or modelling of the emergence potential of vector-borne diseases.

Previous experience with West Nile virus in the United States suggests that a newly introduced vector-borne virus can establish itself and re-emerge after overwintering through trans-ovarial transmission [2-4]. We believe that the 2007 situation in Emilia Romagna should stimulate large scale studies aimed at the surveillance of chikungunya virus infected Ae. albopictus that could hatch from the infected eggs laid by females at the end of their active period. Although three studies suggested that chikungunya virus was not transmitted trans-ovarially [5-7], there is a need to confirm these data through additional studies. Whether chikungunya virus-infected eggs have the potential to initiate a new epidemic in summer 2008 is unknown, but must be taken into account as a serious issue for Italy and other European countries.

Rémi N. Charrel (, Xavier de Lamballerie
Department of emerging viruses UMR190, Aix Marseille University - Institute for Research and Development, Marseille, France



  1. Angelini R, Finarelli AC, Angelini P, Po C, Petropulacos K, Silvi G, et al. Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill 2007;12:E071122.2. Available from:
  2. Baqar S, Hayes CG, Murphy JR, Watts DM. Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. Am J Trop Med Hyg. 1993;48:757-62.
  3. Dohm DJ, Sardelis MR, Turell MJ. Experimental vertical transmission of West Nile virus by Culex pipiens (Diptera: Culicidae). J Med Entomol. 2002;39:640-4.
  4. Goddard LB, Roth AE, Reisen WK, Scott TW. Vertical transmission of West Nile Virus by three California Culex (Diptera: Culicidae) species. J Med Entomol. 2003;40:743-6.
  5. Hundekar SL, Thakare JP, Gokhale MD, Barde PV, Argade SV, Mourya DT. Development of monoclonal antibody based antigen capture ELISA to detect chikungunya virus antigen in mosquitoes. Indian J Med Res. 2002;115:144-8.
  6. Mourya DT. Absence of transovarial transmission of Chikungunya virus in Aedes aegypti and Ae. albopictus mosquitoes. Indian J Med Res. 1987;85:593-5.
  7. Jupp PG, McIntosh BM, Dos Santos I, DeMoor P. Laboratory vector studies on six mosquito and one tick species with chikungunya virus. Trans R Soc Trop Med Hyg. 1981;75:15-9.


Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.